Eli Lilly and Company (NYSE: LLY) to Acquire Centessa Pharmaceuticals
Expert Analysis The acquisition of Centessa Pharmaceuticals by Eli Lilly and Company (NYSE: LLY) marks a significant strategic expansion for Lilly in the biotechnology sector. This deal allows Lilly to enhance its pipeline with innovative biopharmaceutical assets, supporting its long-term growth and commitment to cutting-edge therapies. The integration of Centessa’s assets is expected to strengthen Lilly’s position in diverse therapeutic areas and accelerate the delivery of novel treatments to patients…
